Gaurav A Upadhyay to Defibrillators, Implantable
This is a "connection" page, showing publications Gaurav A Upadhyay has written about Defibrillators, Implantable.
Connection Strength
5.785
-
Predicting Malignant Ventricular Arrhythmias Using Real-Time Remote Monitoring. J Am Coll Cardiol. 2023 03 14; 81(10):949-961.
Score: 0.757
-
Population-Level Impact of the Guidelines Update on Patient Selection and Outcomes After Cardiac Resynchronization Therapy. JACC Clin Electrophysiol. 2022 05; 8(5):651-661.
Score: 0.709
-
Incidence and Clinical Significance of New-Onset Device-Detected Atrial Tachyarrhythmia: A Meta-Analysis. Circ Arrhythm Electrophysiol. 2018 03; 11(3):e005393.
Score: 0.534
-
Pushing and recognizing the limits of nonresponse to cardiac resynchronization therapy: A valuable "negative" trial. Heart Rhythm. 2018 06; 15(6):877-878.
Score: 0.531
-
The burden of inappropriate shocks in young people and how to avoid them. Heart. 2012 Oct; 98(19):1457-66.
Score: 0.367
-
Making a splash? -Intrathoracic impedance and the prediction of arrhythmic events.-. Circ J. 2011; 75(11):2539-40.
Score: 0.342
-
Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial. Circ Arrhythm Electrophysiol. 2024 Dec; 17(12):e012836.
Score: 0.213
-
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial. Circ Cardiovasc Qual Outcomes. 2024 11; 17(11):e010822.
Score: 0.213
-
Association between COVID-19 vaccination and atrial arrhythmias in individuals with cardiac implantable electronic devices. J Cardiovasc Electrophysiol. 2024 Sep; 35(9):1828-1836.
Score: 0.208
-
Predictors of Shock-Reduction Programming and Its Impact on Implantable Cardioverter-Defibrillator Therapies and Mortality: The CERTITUDE Registry. J Am Heart Assoc. 2024 Aug 06; 13(15):e034500.
Score: 0.208
-
Machine learning for prediction of ventricular arrhythmia episodes from intracardiac electrograms of automatic implantable cardioverter-defibrillators. Heart Rhythm. 2024 Nov; 21(11):2295-2302.
Score: 0.206
-
Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System. J Am Coll Cardiol. 2023 08 01; 82(5):383-397.
Score: 0.194
-
Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial. Eur Heart J. 2022 12 14; 43(47):4872-4883.
Score: 0.186
-
Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial. Circulation. 2022 02; 145(5):321-329.
Score: 0.173
-
Empiric ablation of polymorphic ventricular tachycardia/fibrillation in the absence of a mappable trigger: Prospective feasibility and efficacy of pacemap matching to defibrillator electrograms. Heart Rhythm. 2022 04; 19(4):527-535.
Score: 0.172
-
Atypical pathogens associated with cardiac implantable electronic device infections. Pacing Clin Electrophysiol. 2021 Sep; 44(9):1549-1561.
Score: 0.169
-
Characterization of Lead Adherence Using Intravascular Ultrasound to Assess Difficulty of Transvenous Lead Extraction. Circ Arrhythm Electrophysiol. 2020 08; 13(8):e007726.
Score: 0.157
-
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems. J Am Coll Cardiol. 2018 04 03; 71(13):1483-1493.
Score: 0.134
-
Cybersecurity for Cardiac Implantable Electronic Devices: What Should You Know? J Am Coll Cardiol. 2018 03 20; 71(11):1284-1288.
Score: 0.133
-
Cause of death and CRT device selection: striving for certitude? Eur Heart J. 2015 Nov 01; 36(41):2777-9.
Score: 0.113
-
Implantation of cardiac electronic devices in active COVID-19 patients: Results from an international survey. Heart Rhythm. 2022 02; 19(2):206-216.
Score: 0.043
-
Usefulness of hemoglobin A(1c) to predict outcome after cardiac resynchronization therapy in patients with diabetes mellitus and heart failure. Am J Cardiol. 2012 Sep 01; 110(5):683-8.
Score: 0.022